Insider Title Company Date Price Return Shares Value
Landis G. Michael Chief Financial Officer Polaryx Therapeutics, Inc. (PLYX) 2026-02-18 $2.79 0.0% 2,867 $7,991
Return Profit / (loss) Cost
Total 0.0% $0 $7,991